Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.

management polymyalgia rheumatica treatment

Journal

Rheumatology advances in practice
ISSN: 2514-1775
Titre abrégé: Rheumatol Adv Pract
Pays: England
ID NLM: 101736676

Informations de publication

Date de publication:
2024
Historique:
received: 25 09 2023
accepted: 28 12 2023
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 19 2 2024
Statut: epublish

Résumé

The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development.

Identifiants

pubmed: 38371294
doi: 10.1093/rap/rkae002
pii: rkae002
pmc: PMC10871769
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

rkae002

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Auteurs

Task Toyoda (T)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Zoe Armitstead (Z)

Department of Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Sampada Bhide (S)

East Elmbridge Primary Care Network, Kingston Hospital NHS Foundation Trust, Kingston upon Thames, UK.

Serge Engamba (S)

Norwich Practices Health Centre, Norwich, UK.

Emma Henderson (E)

Department of Rheumatology, Stockport NHS Foundation Trust, Stockport, UK.

Claire Jones (C)

Powys Teaching Health Board, Bronllys Hospital, Brecon, UK.

Pieter MacKeith (P)

Norwich Medical School, University of East Anglia, Norwich, UK.

Janice Maddock (J)

Patient Expert, PMRGCAuk, UK.

Gary Reynolds (G)

Centre for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, USA.

Nicola Scrafton (N)

Department of Rheumatology, Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK.

Manil Subesinghe (M)

King's College London and Guy's and St Thomas' PET Centre, London, UK.
Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.

Sujith Subesinghe (S)

Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Helen Twohig (H)

School of Medicine, Keele University, Keele, UK.

Sarah L Mackie (SL)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Max Yates (M)

Norwich Medical School, University of East Anglia, Norwich, UK.
Rheumatology Department, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.

Classifications MeSH